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Acinetobacter baumannii is a multidrug resistant pathogenic bacteria associated with hospital acquired infections. This bacterium
possesses a variety of resistance mechanisms which makes it more difficult to control the bacterium with conventional drugs, and,
so far no effective drug treatment is available against it. Nucleoside diphosphate kinase is an important enzyme, which maintains
the total nucleotide triphosphate pool inside the cell by the transfer of 𝛾-phosphate from NTPs to NDPs. The role of nucleoside
diphosphate kinase (Ndk) has also been observed in pathogenesis in other organisms. However, intensive studies are needed to
decipher its other putative roles inAcinetobacter baumannii. In the present study,we have successfully cloned the gene encodingNdk
and achieved overexpression in bacterial host BL-21 (DE3). The overexpressed protein is further purified by nickel-nitrilotriacetic
acid (Ni-NTA) chromatography.
1. Introduction
Acinetobacter baumannii is an aerobic gram-negative bac-
terium, widely known for its multidrug resistance [1]. It is an
opportunistic bacterial pathogen and possesses wide variety
of resistance mechanisms [2–4]. It has high survival rate on
abiotic surfaces and has the ability to persist in the hospital
environment [3]. Hence, it is largely responsible for hospital-
acquired infections as well as community-acquired infections
[2, 3]. Previously, it has been reported that the infections
caused by this pathogen were of moderate severity; however,
the recently increased prevalence of this bacterial infection
with serious consequences has been observed [3–5]. These
include bacteremia, pneumonia, meningitis, urinary tract,
and wound infections [4].
Nucleoside diphosphate kinase (Ndk) is involved in the
catalysis of the transfer of 𝛾-phosphate from nucleoside
triphosphate to nucleoside diphosphate and thus maintains
the nucleotide pool [6, 7]. The dNTPs that are formed are
used as precursors for DNA and RNA synthesis. NTPs,
specifically GTP, are important for cellular macromolec-
ular synthesis and signalling mechanisms. Ndk has been
found to play a pivotal role in crucial events like bacterial
growth, signal transduction, and pathogenicity [8]. The role
of Ndk in regulating growth, formation of NTP, and cell
surface polysaccharides has been seen in pathogens like
Pseudomonas aeruginosa andMycobacterium tuberculosis [8–
10]. Mycobacterial Ndk has been found to inhibit phagosome
maturation and helps in the survival of the bacterium within
the macrophage [11]. Ndk has also been shown to form
different oligomeric structures in different species which is
often linked to its diversified functions [12–16]. However, the
exact molecular mechanism of the structural and functional
aspects of Ndk in Acinetobacter baumannii has not been
fully deciphered. Here we report the cloning, expression, and
purification of Ndk from Acinetobacter baumannii.
2. Materials and Methods
2.1. Gene Cloning. Escherichia coli strains DH5𝛼 (Invitrogen,
California, USA) and BL-21 (DE3) (Novagen, Wisconsin,
USA) were used for cloning and expression of the recom-
binant protein, respectively. The E. coli cells harbouring
recombinant plasmids were grown aerobically at 37∘C in
Luria-Bertani (Merck, Darmstadt, Germany) broth with or
without 50 𝜇g/mL kanamycin (Sigma, Saint Louis, MO,
USA). Plasmid pET-28a (Novagen, Wisconsin, USA) was













Figure 1: Agarose gel showing the amplification of nucleoside
diphosphate kinase gene. Lane 1 is 100 bp plus DNA ladder, and lane












5819 bp (pET 28a + Ndk)
Figure 2: Agarose gel showing confirmation of insert in pET 28a.
lane 1 is 100 bp DNA ladder, lane 2 is uncut pET 28a-Ndk construct
and lane 3 is restriction digestion of pET 28a-Ndk gene.
The full coding sequence of Ndk was amplified by pol-
ymerase chain reaction (PCR) using forward primer (5󸀠-
GGA ATT CCA TAT GGC AAT TGA ACG TAC TTT G-
3󸀠) incorporated an NdeI restriction enzyme site and reverse
primer (5󸀠CCG CTC GAG TTA ACG AGT GCG TGG GCA
-3󸀠) incorporated an XhoI site.
The purified Ndk fragment was digested with the restric-
tion enzymes NdeI and XhoI and ligated into the NdeI-XhoI
sites of pET28a vector, which provides six His residues at
theN-terminus of the expressed protein. Recombinant vector










Figure 3: SDS-PAGE showing the purity of protein: lane 1 and 2 is
purified Ndk and lane 3 is protein molecular weight marker.
cells. The integrity of the recovered plasmid was confirmed
by restriction endonuclease digestion and sequencing of the
Ndk.
2.2. Expression andPurification. For expression of the recom-
binant protein, pET28a-Ndk plasmid was transformed into
competent Bl-21 (DE3) cells. Bl-21 (DE3) cells harbour-
ing a pET28a-Ndk vector were grown in LB medium
supplemented with kanamycin (50𝜇g/mL) at 37∘C with
shaking (250 rpm) until the absorbance at 600 nm reached
approximately 0.5. Then, isopropyl-𝛽-D-thiogalactopyrano-
side (IPTG)was added to a final concentration of 0.4mmol/L.
The cells were incubated for a further 4 hours before being
harvested. Pellet of Bl-21 cells harbouringNdkwas suspended
by gentle stirring in buffer (50mM, Tris 150mM NaCl, pH
8). The suspension was subjected to sonication (five cycles,
1 minute each, with intervals of 1min in ice) and then
centrifuged for 20 minutes at 6000×g. After centrifugation,
the supernatant and precipitate were examined by sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) to verify the position of the expressed protein.
Ndk was purified by affinity chromatography on a nickel-
nitrilotriacetic acid (Ni-NTA) gel matrix (Qiagen, Crawley,
United Kingdom). A column containing 3mL of Ni-NTA
resin was equilibrated with 10 volumes of buffer containing
50mM Tris, 150mM NaCl, (pH 8.0), and supernatant was
loaded onto the column. The column was washed with 5
volumes of wash buffer containing 50mM Tris pH 8.0,
150mM NaCl, and 30mM imidazole. The protein was then
eluted by increasing the imidazole concentration to 300mM.
Fractions containing the recombinant protein were pooled
and dialyzed to remove Imidazole. Protein concentrations
were determined by Nanodrop analyzer (Bio-Rad, Hercules,
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Figure 4: (a) Effect of increasing urea concentrations on fluorescence intensity of Ndk. (b) Effect of increasing concentrations of ATP on
fluorescence intensity of Ndk at 3 different pH conditions: acidic (󳶃), neutral (∙) and basic (◼). (c) The binding curve of ATP with Ndk. The




in percent was plotted against increasing ATP concentrations.
CA, USA), and the purity was determined by SDS-PAGE and
Coomassie blue staining.
2.3. Characterization Studies of Ndk. Fluorescence spec-
troscopy was used to further characterize the enzyme in
terms of stability, pH, and substrate concentrations. The
change in fluorescence emission spectra were recorded in F-
7000 FL spectrophotometer at 25∘C. The emission spectra
were recorded in range of 300 nm–450 nm with excitation
at 280 nm. The final concentration of the protein was 1.7 ×
10−5M. Stability of the protein was measured by incubating
the protein in increasing concentrations of urea from 0M
to 8M overnight at 4∘C and fluorescence spectra were
recorded at each of the different concentrations of urea.
The substrate binding characteristics of the enzyme were
studied by titrating ATP at different concentrations from 2
× 10−5M–10 × 10−5M and spectra were recorded at each of
these different ATP concentrations. For pH characterization,
the change in spectra due to ATP binding was recorded by
varying the pH of the buffer: acidic pH 5.6, neutral pH 7 and
basic pH 8.5.
3. Results and Discussion
Specific primers were designed to amplify Ndk from the
Acinetobacter baumannii (Figure 1). The amplified Ndk gene
was subcloned in pET 28a vector. The integrity of the
recombinant vector pET28a-Ndk was confirmed by double
digestion usingNdeI andXhoI restriction enzymes (Figure 2).
Identity and orientation of Ndk in the construct was con-
firmed by sequencing the recombinant vector. Cloned Ndk
gene sequence showed 100% homology with the reference
sequences. E. coli Bl-21(DE3) cells harbouring pET28a-Ndk
plasmid were cultured at 37∘C in the presence and absence
of an inducer IPTG. Induction of the cells with IPTG
(0.4mmol/L) at 37∘C for 4 h was found to be optimal to
achieve high-level expression of Ndk. Both supernatant and
the pellet of cell lysates were tested for the presence of
recombinant proteins, and the majority of the expressed
protein was detected in supernatant. Recombinant protein
was carefully purified with Ni-NTA affinity chromatography
(Figure 3). The output of Ndk was approximately 50% of
the total bacterial proteins, and the highest detectable level
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of purified Ndk was up to 3mg/mL. Further studies in this
regard will help in understanding the physiological role of
Ndk in these pathogenic bacteria.
Further characterization studies of this enzyme in terms
of stability, pH, and substrate concentrations were carried
out by exploiting the fluorescence properties of the enzyme.
The fluorescence spectra were recorded in the presence of
increasing concentrations of urea (0M–8M). Fluorescence
intensities in percent were plotted with increasing urea
concentrations (Figure 4(a)). The decrease in fluorescence
intensity of the protein with increasing urea concentration
indicates denaturation of Ndk by urea [17], and complete
denaturation was observed after 6M urea. The error bars on
the experimental points were calculated from the average of
values that were obtained by repeating each experiment five
times.
Binding of the substrate ATP with the enzyme was
confirmed by the quenching of fluorescence intensity with
increasing concentrations of ATP [18, 19]. The spectra for the
enzyme with increasing ATP concentrations were recorded
at 3 different pH conditions. The fluorescence intensities in
percent were plotted with increasing ATP concentrations at
different pH conditions (Figure 4(b)). Maximum quenching
was observed at neutral pH indicating maximum binding of
ATP with Ndk at neutral pH.The observed fluorescence data
at neutral pH were further used for estimating the resultant





of 𝑄 in percent against ATP concentration was prepared
(Figure 4(c)). The 𝑅2 values which indicate the goodness of
the fit of the curve were obtained using SigmaPlot 8.0 [20]
andwere 0.99.The error bars on the experimental points were
calculated from the average of values obtained by repeating
each experiment five times.
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